382 related articles for article (PubMed ID: 16484126)
1. Inflammatory bowel disease after liver transplantation: a role for cytomegalovirus infection.
Verdonk RC; Haagsma EB; Van Den Berg AP; Karrenbeld A; Slooff MJ; Kleibeuker JH; Dijkstra G
Scand J Gastroenterol; 2006 Feb; 41(2):205-11. PubMed ID: 16484126
[TBL] [Abstract][Full Text] [Related]
2. Five cases of de novo inflammatory bowel disease after orthotopic liver transplantation.
Wörns MA; Lohse AW; Neurath MF; Croxford A; Otto G; Kreft A; Galle PR; Kanzler S
Am J Gastroenterol; 2006 Aug; 101(8):1931-7. PubMed ID: 16790037
[TBL] [Abstract][Full Text] [Related]
3. Risk factors associated with cytomegalovirus-positive antigenemia in orthotopic liver transplant patients.
Hoppe L; Bressane R; Lago LS; Schiavo FL; Marroni CA; Keiserman DR; Brandão AB; Júnior AM; Cassal AP; Zanotelli ML; Cantisani GP
Transplant Proc; 2004 May; 36(4):961-3. PubMed ID: 15194334
[TBL] [Abstract][Full Text] [Related]
4. [Clinical course of inflammatory bowel disease in patients transplanted for primary sclerosing cholangitis].
Villamil A; De Paula JA; Galdame O; Piccioni H; Ciardullo M; De Santibañes E; Gadano A
Acta Gastroenterol Latinoam; 2008 Dec; 38(4):252-9. PubMed ID: 19157380
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory bowel disease following solid organ transplantation.
Hampton DD; Poleski MH; Onken JE
Clin Immunol; 2008 Sep; 128(3):287-93. PubMed ID: 18708022
[TBL] [Abstract][Full Text] [Related]
6. Cytomegalovirus infection in inflammatory bowel disease patients undergoing anti-TNFalpha therapy.
D'Ovidio V; Vernia P; Gentile G; Capobianchi A; Marcheggiano A; Viscido A; Martino P; Caprilli R
J Clin Virol; 2008 Oct; 43(2):180-3. PubMed ID: 18614396
[TBL] [Abstract][Full Text] [Related]
7. [pp65 antigenemia in evaluation of cytomegalovirus infection after kidney transplantation].
Orlić P; Dvornik S; Husnjak SC; Aralica M; Orlić L; Zivcić-Cosić S; Sladoje-Martinović B; Fućak M
Acta Med Croatica; 2003; 57(1):49-52. PubMed ID: 12876863
[TBL] [Abstract][Full Text] [Related]
8. The risk factors for cytomegalovirus syndrome and tissue-invasive cytomegalovirus disease in liver transplant recipients who have cytomegalovirus antigenemia.
Kim JM; Kim SJ; Joh JW; Shin M; Moon JI; Jung GO; Choi GS; Kwon CH; Lee SK
Transplant Proc; 2010 Apr; 42(3):890-4. PubMed ID: 20430198
[TBL] [Abstract][Full Text] [Related]
9. Association of cytomegalovirus infection with human leukocyte antigen genotypes in recipients after allogeneic liver transplantation.
Fan J; Meng XQ; Yang MF; Zhou L; Chen XM; Hu MJ; Fan WW; Ma WH; Li LJ
Hepatobiliary Pancreat Dis Int; 2006 Feb; 5(1):34-8. PubMed ID: 16481279
[TBL] [Abstract][Full Text] [Related]
10. Cytomegalovirus infection in children who underwent hematopoietic stem cell transplantation at a single center: a retrospective study of the risk factors.
Yoon HS; Lee JH; Choi ES; Seo JJ; Moon HN; Kim MN; Im HJ
Pediatr Transplant; 2009 Nov; 13(7):898-905. PubMed ID: 19032414
[TBL] [Abstract][Full Text] [Related]
11. Outcome of cytomegalovirus infections in patients with inflammatory bowel disease.
Papadakis KA; Tung JK; Binder SW; Kam LY; Abreu MT; Targan SR; Vasiliauskas EA
Am J Gastroenterol; 2001 Jul; 96(7):2137-42. PubMed ID: 11467645
[TBL] [Abstract][Full Text] [Related]
12. Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis.
Vera A; Gunson BK; Ussatoff V; Nightingale P; Candinas D; Radley S; Mayer A; Buckels JA; McMaster P; Neuberger J; Mirza DF
Transplantation; 2003 Jun; 75(12):1983-8. PubMed ID: 12829898
[TBL] [Abstract][Full Text] [Related]
13. De novo ulcerative colitis and autoimmune hepatitis after living related liver transplantation from cytomegalovirus-positive donor to cytomegalovirus-negative recipient: a case report.
Sakamoto T; Sato Y; Yamamoto S; Oya H; Hatakeyama K
Transplant Proc; 2012 Mar; 44(2):570-3. PubMed ID: 22410071
[TBL] [Abstract][Full Text] [Related]
14. Evidence for an increased rate of bacterial infections in liver transplant patients with cytomegalovirus infection.
van den Berg AP; Klompmaker IJ; Haagsma EB; Peeters PM; Meerman L; Verwer R; The TH; Slooff MJ
Clin Transplant; 1996 Apr; 10(2):224-31. PubMed ID: 8664524
[TBL] [Abstract][Full Text] [Related]
15. Cytomegalovirus infection of the liver transplant: virological, histological, immunological, and clinical observations.
Lautenschlager I; Halme L; Höckerstedt K; Krogerus L; Taskinen E
Transpl Infect Dis; 2006 Mar; 8(1):21-30. PubMed ID: 16623817
[TBL] [Abstract][Full Text] [Related]
16. Risk factors of cytomegalovirus infection after living donor liver transplantation.
Akamatsu N; Sugawara Y; Kaneko J; Kishi Y; Makuuchi M
Hepatogastroenterology; 2005; 52(61):197-9. PubMed ID: 15783029
[TBL] [Abstract][Full Text] [Related]
17. HHV-6 and HHV-7 antigenemia related to CMV infection after liver transplantation.
Härmä M; Höckerstedt K; Lyytikäinen O; Lautenschlager I
J Med Virol; 2006 Jun; 78(6):800-5. PubMed ID: 16628583
[TBL] [Abstract][Full Text] [Related]
18. Persisting posttransplantation cytomegalovirus antigenemia correlates with poor lymphocyte proliferation to cytomegalovirus antigen and predicts for increased late relapse and treatment failure.
Nakamura R; Battiwalla M; Solomon S; Follmann D; Chakrabarti S; Cortez K; Hensel N; Childs R; Barrett AJ
Biol Blood Marrow Transplant; 2004 Jan; 10(1):49-57. PubMed ID: 14752779
[TBL] [Abstract][Full Text] [Related]
19. Is combined pretransplantation seropositivity of kidney transplant recipients for cytomegalovirus antigens (pp150 and pp28) a predictor for protection against infection?
Essa S; Pacsa A; Said T; Nampoory MR; Raghupathy R; Johny KV; Al-Nakib W; Al-Mosawy M
Med Princ Pract; 2008; 17(1):66-70. PubMed ID: 18059104
[TBL] [Abstract][Full Text] [Related]
20. [The prevention and treatment of cytomegalovirus infection after liver transplantation].
Zheng SS; Jiang ZJ; Xu X; Liang TB; Wang WL; Shen Y; Zhang M; Lu AW
Zhonghua Wai Ke Za Zhi; 2005 May; 43(9):584-6. PubMed ID: 15938930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
